Literature DB >> 23105274

Breast and prostate cancer.

B K Sharma1, A Ray.   

Abstract

There are interesting similarities between carcinomas of the breast and prostate. Both genetic and exogenous factors are probably important in the development of breast and prostate cancers. Since there is an alarming increasing trend in the incidence of both cancers worldwide including India, high level of apprehension/awareness has been created among the general educated population. Furthermore, both cancers are strongly linked with the expression of the c-erbB-2 oncogene which has been the focus of basic research in the recent past. This gene belongs to the family of growth factor receptors and it has important implication in diagnosis and future treatment modalities.

Entities:  

Keywords:  Breast cancer; c-erbB-2 oncoprotein; prostate cancer

Year:  2000        PMID: 23105274      PMCID: PMC3454086          DOI: 10.1007/BF02867550

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  40 in total

1.  Androgens and breast cancer in premenopausal women.

Authors:  G Secreto; P Toniolo; P Pisani; C Recchione; A Cavalleri; G Fariselli; A Totis; S Di Pietro; F Berrino
Journal:  Cancer Res       Date:  1989-01-15       Impact factor: 12.701

2.  Immunohistochemical expression of c-erbB-2 oncoprotein and EGF-R in pre- and postmenopausal breast cancer.

Authors:  N Ratnakar; B K Sharma; K U Chaturvedi; S Kaur; S L Naik; A Ray
Journal:  APMIS       Date:  1998-11       Impact factor: 3.205

Review 3.  The control of breast cancer. A World Health Organization perspective.

Authors:  V Koroltchouk; K Stanley; J Stjernswärd
Journal:  Cancer       Date:  1990-06-15       Impact factor: 6.860

Review 4.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

5.  [Immunohistochemical analysis of p53 and c-erbB-2 in breast cancer].

Authors:  T Castiglioni; B Elsner; H P Curutchet; M Montesinos; D Debonis
Journal:  Medicina (B Aires)       Date:  1995       Impact factor: 0.653

6.  Immunohistochemical co-expression of c-erbb-2/Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast.

Authors:  B K Sharma; A Ray; S Kaur; S Gupta
Journal:  Indian J Exp Biol       Date:  1999-03       Impact factor: 0.818

7.  Nonprostatic sources of prostate-specific antigen.

Authors:  E P Diamandis; H Yu
Journal:  Urol Clin North Am       Date:  1997-05       Impact factor: 2.241

8.  Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues.

Authors:  P G Natali; M R Nicotra; A Bigotti; I Venturo; D J Slamon; B M Fendly; A Ullrich
Journal:  Int J Cancer       Date:  1990-03-15       Impact factor: 7.396

9.  Serum sex hormone levels are related to breast cancer risk in postmenopausal women.

Authors:  J F Dorgan; C Longcope; H E Stephenson; R T Falk; R Miller; C Franz; L Kahle; W S Campbell; J A Tangrea; A Schatzkin
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

10.  Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer.

Authors:  N Zarghami; L Grass; E P Diamandis
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  2 in total

1.  Serum levels of metal ions in female patients with breast cancer.

Authors:  V Pavithra; T G Sathisha; K Kasturi; D Siva Mallika; S Jeevan Amos; S Ragunatha
Journal:  J Clin Diagn Res       Date:  2015-01-01

2.  Studies of biochemical parameters in breast cancer with and without metastasis.

Authors:  Sandhya Mishra; D C Sharma; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2004-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.